Newer Clinical Application of Pacing. For many years, the indications
for permanent cardiac pacing consisted primarily of AV block and sinus
mode dysfunction. In recent years, the indications for pacing have ex
panded considerably. This article details recent advances in the appli
cation of permanent pacing and the use of permanent pacing for patient
s with hypertrophic cardiomyopathy, dilated cardiomyopathy, prevention
of atrial fibrillation, and pacing in the long QT syndrome. Pacing is
now an accepted therapeutic modality in hypertrophic cardiomyopathy a
nd has rapidly gained acceptance in the United States, although there
are still many unknowns about selection of patients and long-term bene
fits. Even less is known about pacing for dilated cardiomyopathy. Cert
ain patients do respond with definite subjective improvement and impro
ved quality of life, although there are no data to date to suggest imp
roved longevity. Pacing for long QT syndrome is mow a wen-accepted ind
ication for this relatively small subset of patients. Pacing for the p
revention of atrial fibrillation is still in the very early stages of
development. Multiple methods have been tried with the current method
of choice being dual site atrial pacing. However, it is too early to p
redict the long-term success of this modality.